Zoledronic Acid for Injection

Active Ingredients: Zoledronic Acid

Zoledronic Acid for Injection is a drug used to treat osteoporosis in postmenopausal women, as it reduces the incidence of fractures. It is also used to treat hypercalcemia caused by some types of cancer and to treat bone damage caused by multiple myeloma or cancer that has spread through the body.

Note that Zoledronic Acid for Injection is not an anticancer chemotherapy drug, and it will not slow or stop the spread of cancer, however, can be used to treat bone disease in patients who have cancer.

Zoledronic Acid for Injection is in a group of medicines called bisphosphonates, which inhibits the release of calcium from bones.

Zoledronic Acid for Injection is produced in our GMP-certified facilities located in China, India, and the USA. Our factories are routinely inspected to ensure they meet the high standards necessary to comply with WHO guidelines and standards. AdvaCare Pharma is proud to offer a wide range of high-quality and cost-effective oncology medications that are available for distribution.

AdvaCare Pharma manufactures Zoledronic Acid Injection, one of 40+ oncology treatments, according to rigorous GMP protocols at our state-of-the-art production facility. We are committed to producing quality-assured, cost-effective cancer treatments that meet the highest industry standards and are readily available to cancer patients worldwide. As an established Zoledronic Acid manufacturer, we supply pharmaceutical distributors, hospitals and government institutions with reliable cancer drugs.

What is Zoledronic Acid used for?

It is used to treat hypercalcemia as a side effect of chemotherapy treatment. Zoledronic Acid is also used to treat osteoporosis in postmenopausal women.

How should Zoledronic Acid for Injection be used?

This medication is manufactured as a powder and stored in a vial. The powder is to be prepared into a solution, and after reconstitution, it should be administered by injection into a vein.

What dose should be given?

For malignant hypercalcemia, the usual dose is 4mg IV. Secondary treatment may be given after 7 days, if necessary.

The injection might take 15 minutes to complete.

The usual dose for an adult is dependent on the disease and treatment plan. Refer to a doctor or pharmacist for guidelines on dosage. Do not exceed what they advise.

As with all pharmaceuticals, some unwanted effects can occur from the use of Zoledronic Acid for Injection.

For a comprehensive list of all possible side effects, Consult a doctor.

If any symptoms persist or worsen, or you notice any other symptoms, please call your doctor immediately.

Consult with your doctor about any medications you are taking before beginning treatment with Zoledronic Acid for Injection.

The use of Zoledronic Acid Powder during pregnancy or breastfeeding is not recommended because it can harm the fetus or baby. Consult a doctor or healthcare professional before treatment with Zoledronic Acid.